GR

Greatland Resources Limited

A gold and copper producer operating and developing mines in Western Australia's Paterson region.

GGP | IL

Overview

Corporate Details

ISIN(s):
AU0000397705
LEI:
213800KQI75ZGE53GX44
Country:
Australia
Address:
LEVEL 3, 502 HAY STREET, 6008 SUBIACO
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Greatland Resources Limited is a gold and copper producer engaged in the discovery, development, extraction, and processing of precious and base metals. The company's principal assets are located in the Paterson region of Western Australia. It operates the Telfer gold-copper mine, a large-scale mining complex with significant processing infrastructure. Concurrently, Greatland is developing the nearby high-grade Havieron gold-copper project, which is designed to utilize the existing Telfer facilities for ore processing. The company also maintains a substantial exploration portfolio in the region. Greatland's strategy is to become a profitable multi-mine resources company through responsible and sustainable operations.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-10 09:35
Major Shareholding Notification
Holding(s) in Company
English 108.6 KB
2025-10-27 10:45
Major Shareholding Notification
Holding(s) in Company
English 102.8 KB
2025-10-23 08:46
Report Publication Announcement
September 2025 Quarter Results
English 13.2 KB
2025-10-22 09:52
Regulatory News Service
September 2025 Quarter Drilling Update
English 20.2 KB
2025-10-10 09:42
Investor Presentation
Corporate Presentation
English 10.9 KB
2025-10-10 08:55
Pre-Annual General Meeting Information
2025 Notice of Annual General Meeting
English 11.9 KB
2025-10-09 08:00
Board/Management Information
Appointment of Joint Corporate Broker
English 11.2 KB
2025-10-07 08:00
Earnings Release
September 2025 Quarter Production Update
English 14.6 KB
2025-09-26 08:44
Remuneration Information
Director/PDMR Shareholding
English 32.6 KB
2025-09-25 08:24
Report Publication Announcement
2025 Annual Report
English 11.0 KB
2025-09-18 09:28
Major Shareholding Notification
Holding(s) in Company
English 107.6 KB
2025-08-28 12:11
Annual Report
Unaudited Prelim FY25 Final Report - Replacement
English 681.4 KB
2025-08-28 09:05
Earnings Release
Unaudited Preliminary FY25 Final Report
English 681.5 KB
2025-08-05 08:49
Investor Presentation
Diggers and Dealers 2025 Presentation
English 12.4 KB
2025-07-29 08:00
Quarterly Report
Quarterly Activities Report - June Quarter 2025
English 527.4 KB

Automate Your Workflow. Get a real-time feed of all Greatland Resources Limited filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Greatland Resources Limited

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Greatland Resources Limited via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.